Verapamil-Induced Subacute Cutaneous Lupus Erythematosus
July 2005 | Volume 4 | Issue 4 | 506 | Copyright © July 2005
Boaz Kurtis MD, Matthew J. Larson MD, Mai P. Hoang MD, Jack B. Cohen DO
Abstract
Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed
class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil. 
